Wednesday, May 10 — 1 significant news

The second COVID-19 vaccine authorized for use in children

Today ChatGPT read 1158 top news and gave 3 of them a significance score over 6.5.

After removing duplicates and repeats, here is today’s significant news:

[7.0] Moderna's COVID-19 vaccine authorized for use in children aged 6 months to 5 years. — News-Medical.Net

The COVID-19 vaccine from Moderna, known as Spikevax, has received approval for use in children ranging from 6 months to 5 years. This decision came after verifying the vaccine's safety, quality, and effectiveness, with no new safety concerns emerging. Spikevax is the second COVID-19 vaccine to receive such authorization, following a similar approval for the Pfizer/BioNTech vaccine last year. The endorsement was based on data from a clinical trial involving over 6,000 children. A special committee is set to decide if the vaccine will be incorporated into the UK's COVID-19 vaccination program for this age group.

Want to read more? See additional news on newsminimalist.com.

Thanks for reading us and see you tomorrow,
News Minimalist

Reply

or to participate.